Alliancebernstein L.P. decreased its position in ATRION Co. (NASDAQ:ATRI) by 4.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,966 shares of the medical instruments supplier’s stock after selling 100 shares during the period. Alliancebernstein L.P. owned 0.11% of ATRION worth $1,240,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of ATRI. Citadel Advisors LLC purchased a new stake in shares of ATRION during the 4th quarter worth approximately $269,000. Teacher Retirement System of Texas purchased a new stake in shares of ATRION during the 4th quarter worth approximately $323,000. Bank of Montreal Can increased its stake in shares of ATRION by 25.7% during the 4th quarter. Bank of Montreal Can now owns 597 shares of the medical instruments supplier’s stock worth $376,000 after purchasing an additional 122 shares during the last quarter. Spark Investment Management LLC purchased a new stake in shares of ATRION during the 4th quarter worth approximately $756,000. Finally, SG Americas Securities LLC purchased a new stake in shares of ATRION during the 4th quarter worth approximately $900,000. Institutional investors own 59.05% of the company’s stock.
Separately, BidaskClub lowered shares of ATRION from a “sell” rating to a “strong sell” rating in a research note on Monday, December 18th.
ATRION (NASDAQ:ATRI) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $4.66 earnings per share (EPS) for the quarter. ATRION had a net margin of 24.96% and a return on equity of 19.53%. The company had revenue of $34.02 million during the quarter.
The business also recently declared a quarterly dividend, which was paid on Friday, March 30th. Stockholders of record on Thursday, March 15th were paid a dividend of $1.20 per share. The ex-dividend date was Wednesday, March 14th. This represents a $4.80 annualized dividend and a dividend yield of 0.79%.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://dakotafinancialnews.com/2018/04/13/alliancebernstein-l-p-has-1-24-million-holdings-in-atrion-co-atri.html.
Atrion Corp. engages in the manufacture and development of products for medical applications. It involves in the marketing of components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. It specializes in the fluid delivery, as well as ophthalmic and cardiovascular devices.
Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ATRION Co. (NASDAQ:ATRI).
Receive News & Ratings for ATRION Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ATRION and related companies with MarketBeat.com's FREE daily email newsletter.